Clinical Trial Update: Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intensified peri-operative chemotherapy in high-risk CINSARC patients with resectable non-metastatic soft-tissue sarcoma. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Institut Bergonié | Conditions: Non-metastatic Soft-tissue Sarcoma, Resectable | Phase 3 | Status: RECRUITING